TRIP6 and colorectal cancer: More importantly, the study reveals a unique immune phenotype associated with the model and its key driver gene, TRIP6, offering new insights into the mechanisms of immune evasion in colorectal cancer and laying a theoretical foundation for strategies targeting histidine metabolism to overcome immunotherapy resistance.